Capsaicin represses transcriptional activity of β-catenin in human colorectal cancer cells

Journal of Nutritional Biochemistry

Volumn 23, Issue 6, 2012, Pages 646-655

  Lee, Seong Ho ^a   Richardson, Raphael L ^a   Dashwood, Roderick H ^b   Baek, Seung Joon ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

^b OREGON STATE UNIVERSITY   (United States)

Author keywords

catenin; Capsaicin; Colorectal cancer; TCF 4

Indexed keywords

BETA CATENIN; CAPSAICIN; LUCIFERASE; T CELL FACTOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

APOPTOSIS; BETA CATENIN; BLOTTING, WESTERN; CAPSAICIN; CAPSICUM; CELL PROLIFERATION; COLORECTAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; IMMUNOPRECIPITATION; PLANT EXTRACTS; PROMOTER REGIONS, GENETIC; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN; TRANSFECTION;

CAPSICUM ANNUUM VAR. ANNUUM;

EID: 84860887229     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2011.03.009     Document Type: Article

References (55)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300.
3. COMA: nutritional aspects of the development of cancer 1998, Health Education Authority, London.
4. Chu Y.F., Sun J., Wu X., Liu R.H. Antioxidant and antiproliferative activities of common vegetables. J Agric Food Chem 2002, 50:6910-6916.
5. Lucier G., Jerardo A. Vegetables and melons outlook 2007, US Department of Agriculture Economic Research Service, Washington, DC, Publication VGS-313.
6. Yoshitani S.I., Tanaka T., Kohno H., Takashima S. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by dietary capsaicin and rotenone. Int J Oncol 2001, 19:929-939.
7. Kim Y.M., Hwang J.T., Kwak D.W., Lee Y.K., Park O.J. Involvement of AMPK signaling cascade in capsaicin-induced apoptosis of HT-29 colon cancer cells. Ann N Y Acad Sci 2007, 1095:496-503.
8. Wu C.C., Lin J.P., Yang J.S., Chou S.T., Chen S.C., Lin Y.T., et al. Capsaicin induced cell cycle arrest and apoptosis in human esophagus epidermoid carcinoma CE 81T/VGH cells through the elevation of intracellular reactive oxygen species and Ca2+ productions and caspase-3 activation. Mutat Res 2006, 601:71-82.
9. Ito K., Nakazato T., Yamato K., Miyakawa Y., Yamada T., Hozumi N., et al. Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res 2004, 64:1071-1078.
10. Mori A., Lehmann S., O'Kelly J., Kumagai T., Desmond J.C., Pervan M., et al. Capsaicin, a component of red peppers, inhibits the growth of androgen-independent, p53 mutant prostate cancer cells. Cancer Res 2006, 66:3222-3229.
11. Brown K.C., Witte T.R., Hardman W.E., Luo H., Chen Y.C., Carpenter A.B., et al. Capsaicin displays anti-proliferative activity against human small cell lung cancer in cell culture and nude mice models via the E2F pathway. PLoS One 2010, 5:e10243.
12. Thoennissen N.H., O'Kelly J., Lu D., Iwanski G.B., La D.T., Abbassi S., et al. Capsaicin causes cell-cycle arrest and apoptosis in ER-positive and -negative breast cancer cells by modulating the EGFR/HER-2 pathway. Oncogene 2010, 29:285-296.
13. Zhang R., Humphreys I., Sahu R.P., Shi Y., Srivastava S.K. In vitro and in vivo induction of apoptosis by capsaicin in pancreatic cancer cells is mediated through ROS generation and mitochondrial death pathway. Apoptosis 2008, 13:1465-1478.
14. Hwang M.K., Bode A.M., Byun S., Song N.R., Lee H.J., Lee K.W., et al. Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1. Cancer Res 2010, 70:6859-6869.
15. Agrawal R.C., Wiessler M., Hecker E., Bhide S.V. Tumour-promoting effect of chilli extract in BALB/c mice. Int J Cancer 1986, 38:689-695.
16. Lee S.H., Krisanapun C., Baek S.J. NSAID-activated gene-1 as a molecular target for capsaicin-induced apoptosis through a novel molecular mechanism involving GSK3{beta}, C/EBP{beta}, and ATF3. Carcinogenesis 2010, 31:719-728.
17. Yang K.M., Pyo J.O., Kim G.Y., Yu R., Han I.S., Ju S.A., et al. Capsaicin induces apoptosis by generating reactive oxygen species and disrupting mitochondrial transmembrane potential in human colon cancer cell lines. Cell Mol Biol Lett 2009, 14:497-510.
18. Kim M.Y., Trudel L.J., Wogan G.N. Apoptosis induced by capsaicin and resveratrol in colon carcinoma cells requires nitric oxide production and caspase activation. Anticancer Res 2009, 29:3733-3740.
19. Kim C.S., Park W.H., Park J.Y., Kang J.H., Kim M.O., Kawada T., et al. Capsaicin, a spicy component of hot pepper, induces apoptosis by activation of the peroxisome proliferator-activated receptor gamma in HT-29 human colon cancer cells. J Med Food 2004, 7:267-273.
20. Min J.K., Han K.Y., Kim E.C., Kim Y.M., Lee S.W., Kim O.H., et al. Capsaicin inhibits in vitro and in vivo angiogenesis. Cancer Res 2004, 64:644-651.
21. Chow J., Norng M., Zhang J., Chai J. TRPV6 mediates capsaicin-induced apoptosis in gastric cancer cells - mechanisms behind a possible new ' hot' cancer treatment. Biochim Biophys Acta 2007, 1773:565-576.
22. Maity R., Sharma J., Jana N.R. Capsaicin induces apoptosis through ubiquitin-proteasome system dysfunction. J Cell Biochem 2010, 109:933-942.
23. Bienz M. APC: the plot thickens. Curr Opin Genet Dev 1999, 9:595-603.
24. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999, 398:422-426.
25. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., et al. Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509-1512.
26. He T.C., Chan T.A., Vogelstein B., Kinzler K.W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999, 99:335-345.
27. van de Wetering M., Sancho E., Verweij C., de Lau W., Oving I., Hurlstone A., et al. The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 2002, 111:241-250.
28. Jaiswal A.S., Marlow B.P., Gupta N., Narayan S. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene 2002, 21:8414-8427.
29. Bocca C., Bozzo F., Francica S., Colombatto S., Miglietta A. Involvement of PPARgamma and E-cadherin/beta-catenin pathway in the antiproliferative effect of conjugated linoleic acid in MCF-7 cells. Int J Cancer 2007, 121:248-256.
30. Dashwood W.M., Orner G.A., Dashwood R.H. Inhibition of beta-catenin/Tcf activity by white tea, green tea, and epigallocatechin-3-gallate (EGCG): minor contribution of H(2)O(2) at physiologically relevant EGCG concentrations. Biochem Biophys Res Commun 2002, 296:584-588.
31. Lee S.H., Yamaguchi K., Kim J.S., Eling T.E., Safe S., Park Y., et al. Conjugated linoleic acid stimulates an anti-tumorigenic protein NAG-1 in an isomer specific manner. Carcinogenesis 2006, 27:972-981.
32. Lee S.H., Cekanova M., Baek S.J. Multiple mechanisms are involved in 6-gingerol-induced cell growth arrest and apoptosis in human colorectal cancer cells. Molecular Carcinogenesis 2008, 47:197-208.
33. Lee S.H., Bahn J.H., Whitlock N.C., Baek S.J. Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways. Oncogene 2010, 29:5182-5192.
34. Nelson W.J., Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
35. Shtutman M., Zhurinsky J., Simcha I., Albanese C., D'Amico M., Pestell R., et al. The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. Proc Natl Acad Sci USA 1999, 96:5522-5527.
36. Aberle H., Bauer A., Stappert J., Kispert A., Kemler R. beta-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J 1997, 16:3797-3804.
37. Surh Y.J. More than spice: capsaicin in hot chili peppers makes tumor cells commit suicide. J Natl Cancer Inst 2002, 94:1263-1265.
38. Hawcroft G., D'Amico M., Albanese C., Markham A.F., Pestell R.G., Hull M.A. Indomethacin induces differential expression of beta-catenin, gamma-catenin and T-cell factor target genes in human colorectal cancer cells. Carcinogenesis 2002, 23:107-114.
39. Kwon I.K., Wang R., Thangaraju M., Shuang H., Liu K., Dashwood R., et al. PKG inhibits TCF signaling in colon cancer cells by blocking beta-catenin expression and activating FOXO4. Oncogene 2010, 29:3423-3434.
40. El-Bahrawy M.A., Poulsom R., Jeffery R., Talbot I., Alison M.R. The expression of E-cadherin and catenins in sporadic colorectal carcinoma. Hum Pathol 2001, 32:1216-1224.
41. El-Bahrawy M.A., Talbot I.C., Poulsom R., Jeffery R., Alison M.R. The expression of E-cadherin and catenins in colorectal tumours from familial adenomatous polyposis patients. J Pathol 2002, 198:69-76.
42. Wang R., Dashwood W.M., Lohr C.V., Fischer K.A., Pereira C.B., Louderback M., et al. Protective versus promotional effects of white tea and caffeine on PhIP-induced tumorigenesis and beta-catenin expression in the rat. Carcinogenesis 2008, 29:834-839.
43. Li Q., Dashwood W.M., Zhong X., Al-Fageeh M., Dashwood R.H. Cloning of the rat beta-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters. Genomics 2004, 83:231-242.
44. Morin P.J., Sparks A.B., Korinek V., Barker N., Clevers H., Vogelstein B., et al. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 1997, 275:1787-1790.
45. Sharma C., Pradeep A., Wong L., Rana A., Rana B. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway. J Biol Chem 2004, 279:35583-35594.
46. Xiao J.H., Ghosn C., Hinchman C., Forbes C., Wang J., Snider N., et al. Adenomatous polyposis coli (APC)-independent regulation of beta-catenin degradation via a retinoid × receptor-mediated pathway. J Biol Chem 2003, 278:29954-29962.
47. Rother K., Johne C., Spiesbach K., Haugwitz U., Tschop K., Wasner M., et al. Identification of Tcf-4 as a transcriptional target of p53 signalling. Oncogene 2004, 23:3376-3384.
48. Sparks A.B., Morin P.J., Vogelstein B., Kinzler K.W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res 1998, 58:1130-1134.
49. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., et al. Control of beta-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 2002, 108:837-847.
50. Mukhopadhyay A., Banerjee S., Stafford L.J., Xia C., Liu M., Aggarwal B.B. Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 2002, 21:8852-8861.
51. Spinella M.J., Freemantle S.J., Sekula D., Chang J.H., Christie A.J., Dmitrovsky E. Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J Biol Chem 1999, 274:22013-22018.
52. Huang J.W., Shiau C.W., Yang Y.T., Kulp S.K., Chen K.F., Brueggemeier R.W., et al. Peroxisome proliferator-activated receptor gamma-independent ablation of cyclin D1 by thiazolidinediones and their derivatives in breast cancer cells. Mol Pharmacol 2005, 67:1342-1348.
53. Amantini C., Ballarini P., Caprodossi S., Nabissi M., Morelli M.B., Lucciarini R., et al. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an A™-dependent manner. Carcinogenesis 2009, 30:1320-1329.
54. Qin C., Burghardt R., Smith R., Wormke M., Stewart J., Safe S. Peroxisome proliferator-activated receptor gamma agonists induce proteasome-dependent degradation of cyclin D1 and estrogen receptor alpha in MCF-7 breast cancer cells. Cancer Res 2003, 63:958-964.
55. Athanasiou A., Smith P.A., Vakilpour S., Kumaran N.M., Turner A.E., Bagiokou D., et al. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death. Biochem Biophys Res Commun 2007, 354:50-55.